Honasa Consumer has called off its proposed acquisition of a 58% stake in Fluence Pharma after the closing conditions under the share purchase agreement were not fulfilled. The FMCG company said it will continue to evaluate organic and inorganic opportunities in the nutraceuticals segment.
